Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Practice Guidelines as Topic × Lymphoid × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 10 Gastrointestinal 9 Breast 8 Thoracic 7 Other solid neoplasm 7 Other hematologic neoplasm 6 Tumor-Agnostic 4 Head & Neck 4 Gynecologic 2 Dermatologic 2 Sarcoma 1 Other neoplasm 1 Other 1 Myeloid 1 Lymphoid 1 CNS 1

Conditions

Interventions

Cyclophosphamide 141 Rituximab 140 venetoclax 81 Specimen Handling 75 Vincristine 72 fludarabine 65 Prednisone 65 Doxorubicin 65 Magnetic Resonance Spectroscopy 62 Biopsy 60 obinutuzumab 55 Lenalidomide 47 ibrutinib 41 Cytarabine 41 Methotrexate 38 Dexamethasone 38 fludarabine phosphate 35 zanubrutinib 34 acalabrutinib 34 CT-P10 33 Etoposide 32 Bendamustine Hydrochloride 29 blinatumomab 28 glofitamab 26 prednylidene 25 pembrolizumab 25 deltacortene 25 Gemcitabine 24 pirtobrutinib 21 polatuzumab vedotin 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05006482 2026-01-13

GEM-S

University of Rochester

Phase 3 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡